The Naproxen Tablets, cataloged under National Stock Number 6505-01-204-5298, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Teva Pharmaceuticals Usa, Inc.. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 9 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-204-5298 |
| Primary Part Number | 00903014801 |
| Item Name | Naproxen Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Teva Pharmaceuticals Usa, Inc. |
| Status | ACTIVE |
| Primary Container Content Quantity | 100.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Features Provided | UNIT DOSE |
| Primary Container Type | STRIP |
| Active Medicament Medicinal Strength | 375.000 MILLIGRAMS NAPROXEN ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| 00903014801 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| NDC00004-6314-01 PRIMARY | Roche Laboratories Inc. (USA) |
| 00004631401 PRIMARY | Roche Laboratories Inc. (USA) |
| NDC18393-0273-53 | Syntex Laboratories Inc (USA) |
| NDC00903-0148-01 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| NDC51079-0794-20 | Mylan Institutional Inc Dba Mylan Institutional (USA) |
| NDC67253-0621-10 PRIMARY | Dava Pharmaceuticals, Inc. (USA) |
| NDC00904-5590-60 | Major Pharmaceuticals Inc (USA) |
| 00904559060 | Major Pharmaceuticals Inc (USA) |
| Reference | Meaning |
|---|---|
| NDC00781-1164-13 | 3/9 Design control — primary reference Geneva Pharmaceuticals Inc |
NSN 6505-01-204-5298 is a Naproxen Tablets, manufactured by Teva Pharmaceuticals Usa, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-204-5298 has 9 manufacturer part numbers on file: 00903014801 (Teva Pharmaceuticals Usa, Inc.), NDC00004-6314-01 (Roche Laboratories Inc.), 00004631401 (Roche Laboratories Inc.), NDC18393-0273-53 (Syntex Laboratories Inc), NDC00903-0148-01 (Teva Pharmaceuticals Usa, Inc.) and 4 more.
Key specifications for 00903014801: Primary Container Content Quantity: 100.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Features Provided: UNIT DOSE; Primary Container Type: STRIP. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.